TrialCNS drugs2006

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.

Pedro J Modrego et al.PubMed ↗Publisher ↗

No numbers read from the abstract.